Sophia Genetics is a health technology company which develops SOPHiA artificial intelligence for clinical genomics used by healthcare institutions worldwide. The Company offers DRY LAB, an analytical solution for treating raw next-generation DNA sequencing (NGS) data; BUNDLE that offers enrichment kit and access to SOPHiA DDM platform; and integrated diagnostic solutions. It also provides SOPHiA DDM, a software-as-a-service platform that enables analysis and protection of clinical NGS data in the areas of oncology, metabolism, pediatrics, cardiology, and hereditary cancer.
|Size (employees)||214 (est)|
Sophia Genetics total Funding
Sophia Genetics latest funding size
Time since last funding
|a year ago|
Sophia Genetics investors
|360 Capital Partners, Invoke Capital Partners, Marc Coucke, Balderton Capital, Alychlo|
Sophia Genetics has 21.68k Twitter Followers. The number of followers has decreased 0.3% month over month and increased 21% quarter over quarter
When was Sophia Genetics founded?
Sophia Genetics was founded in 2011.
Who are Sophia Genetics key executives?
Sophia Genetics's key executives are Jurgi Camblong, Damien Lapray and Valentin Matillon.
How many employees does Sophia Genetics have?
Sophia Genetics has 214 employees.
Who are Sophia Genetics competitors?
Competitors of Sophia Genetics include LYTICS, VoxelCloud and Lunit.
Where is Sophia Genetics headquarters?
Sophia Genetics headquarters is located at 172 Rue du Centre, Saint-Sulpice.
Where are Sophia Genetics offices?
Sophia Genetics has offices in Saint-Sulpice, Montpellier and Cambridgeshire.
How many offices does Sophia Genetics have?
Sophia Genetics has 3 offices.